Different mechanisms in weight loss-induced blood pressure reduction between a calorie-restricted diet and exercise

The present study compared the effectiveness of a mild calorie-restricted diet (D) alone, exercise (EX) alone and a combination of D+EX on weight loss-induced blood pressure (BP) reduction over 24 weeks. We focussed especially on the relationship between sympathetic nervous activity, as indicated fr...

Full description

Saved in:
Bibliographic Details
Published inHypertension research Vol. 35; no. 1; pp. 41 - 47
Main Authors Masuo, Kazuko, Rakugi, Hiromi, Ogihara, Toshio, Lambert, Gavin W
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 01.01.2012
Subjects
Online AccessGet full text
ISSN0916-9636
1348-4214
1348-4214
DOI10.1038/hr.2011.134

Cover

Abstract The present study compared the effectiveness of a mild calorie-restricted diet (D) alone, exercise (EX) alone and a combination of D+EX on weight loss-induced blood pressure (BP) reduction over 24 weeks. We focussed especially on the relationship between sympathetic nervous activity, as indicated from measures of plasma norepinephrine (NE), and insulin resistance (homeostasis model of insulin resistance, HOMA-IR). The three groups each comprised 30 obese, hypertensive men. Body mass index (BMI), fat mass, waist-to-hip ratio, BP, plasma NE and HOMA-IR were measured every 2 weeks during the first 4 weeks and subsequently every 4 weeks for the next 20 weeks. All basal parameters were similar among the three groups. At 24 weeks, the combination group with D+EX comprised a significantly higher prevalence of normotensive subjects than the D alone or EX alone group ( P <0.05). In the D alone group, plasma NE was decreased significantly at 2 weeks, reductions in BMI, fat mass and BP were observed at 8 weeks, and waist-to-hip ratios and HOMA-IR were decreased at 12 weeks. In comparison, in the EX alone group, significant reductions of fat mass and HOMA-IR were observed at 4 weeks. Plasma NE and HOMA-IR were reduced at 8 weeks while decreases in BP were detected at 12 weeks. In the D+EX group, significant reductions in plasma NE were observed at 2 weeks followed by significant decreases in BMI, fat mass, waist-to-hip ratio, BP levels and HOMA-IR at 4 weeks. The magnitudes of reductions of all parameters were greatest in the D+EX group. These results demonstrate that D+EX exerts a stronger ameliorative effect on weight loss, weight loss-induced BP reduction, normalization of BP, sympathetic activation and insulin resistance compared with D or EX alone. D and EX might, perhaps, exert different mechanisms on weight loss and weight loss-induced BP reduction; however, a combination of caloric restriction and exercise is preferred to control BP levels in obese hypertensive patients.
AbstractList The present study compared the effectiveness of a mild calorie-restricted diet (D) alone, exercise (EX) alone and a combination of D+EX on weight loss-induced blood pressure (BP) reduction over 24 weeks. We focussed especially on the relationship between sympathetic nervous activity, as indicated from measures of plasma norepinephrine (NE), and insulin resistance (homeostasis model of insulin resistance, HOMA-IR). The three groups each comprised 30 obese, hypertensive men. Body mass index (BMI), fat mass, waist-to-hip ratio, BP, plasma NE and HOMA-IR were measured every 2 weeks during the first 4 weeks and subsequently every 4 weeks for the next 20 weeks. All basal parameters were similar among the three groups. At 24 weeks, the combination group with D+EX comprised a significantly higher prevalence of normotensive subjects than the D alone or EX alone group (P<0.05). In the D alone group, plasma NE was decreased significantly at 2 weeks, reductions in BMI, fat mass and BP were observed at 8 weeks, and waist-to-hip ratios and HOMA-IR were decreased at 12 weeks. In comparison, in the EX alone group, significant reductions of fat mass and HOMA-IR were observed at 4 weeks. Plasma NE and HOMA-IR were reduced at 8 weeks while decreases in BP were detected at 12 weeks. In the D+EX group, significant reductions in plasma NE were observed at 2 weeks followed by significant decreases in BMI, fat mass, waist-to-hip ratio, BP levels and HOMA-IR at 4 weeks. The magnitudes of reductions of all parameters were greatest in the D+EX group. These results demonstrate that D+EX exerts a stronger ameliorative effect on weight loss, weight loss-induced BP reduction, normalization of BP, sympathetic activation and insulin resistance compared with D or EX alone. D and EX might, perhaps, exert different mechanisms on weight loss and weight loss-induced BP reduction; however, a combination of caloric restriction and exercise is preferred to control BP levels in obese hypertensive patients.The present study compared the effectiveness of a mild calorie-restricted diet (D) alone, exercise (EX) alone and a combination of D+EX on weight loss-induced blood pressure (BP) reduction over 24 weeks. We focussed especially on the relationship between sympathetic nervous activity, as indicated from measures of plasma norepinephrine (NE), and insulin resistance (homeostasis model of insulin resistance, HOMA-IR). The three groups each comprised 30 obese, hypertensive men. Body mass index (BMI), fat mass, waist-to-hip ratio, BP, plasma NE and HOMA-IR were measured every 2 weeks during the first 4 weeks and subsequently every 4 weeks for the next 20 weeks. All basal parameters were similar among the three groups. At 24 weeks, the combination group with D+EX comprised a significantly higher prevalence of normotensive subjects than the D alone or EX alone group (P<0.05). In the D alone group, plasma NE was decreased significantly at 2 weeks, reductions in BMI, fat mass and BP were observed at 8 weeks, and waist-to-hip ratios and HOMA-IR were decreased at 12 weeks. In comparison, in the EX alone group, significant reductions of fat mass and HOMA-IR were observed at 4 weeks. Plasma NE and HOMA-IR were reduced at 8 weeks while decreases in BP were detected at 12 weeks. In the D+EX group, significant reductions in plasma NE were observed at 2 weeks followed by significant decreases in BMI, fat mass, waist-to-hip ratio, BP levels and HOMA-IR at 4 weeks. The magnitudes of reductions of all parameters were greatest in the D+EX group. These results demonstrate that D+EX exerts a stronger ameliorative effect on weight loss, weight loss-induced BP reduction, normalization of BP, sympathetic activation and insulin resistance compared with D or EX alone. D and EX might, perhaps, exert different mechanisms on weight loss and weight loss-induced BP reduction; however, a combination of caloric restriction and exercise is preferred to control BP levels in obese hypertensive patients.
The present study compared the effectiveness of a mild calorie-restricted diet (D) alone, exercise (EX) alone and a combination of D+EX on weight loss-induced blood pressure (BP) reduction over 24 weeks. We focussed especially on the relationship between sympathetic nervous activity, as indicated from measures of plasma norepinephrine (NE), and insulin resistance (homeostasis model of insulin resistance, HOMA-IR). The three groups each comprised 30 obese, hypertensive men. Body mass index (BMI), fat mass, waist-to-hip ratio, BP, plasma NE and HOMA-IR were measured every 2 weeks during the first 4 weeks and subsequently every 4 weeks for the next 20 weeks. All basal parameters were similar among the three groups. At 24 weeks, the combination group with D+EX comprised a significantly higher prevalence of normotensive subjects than the D alone or EX alone group ( P <0.05). In the D alone group, plasma NE was decreased significantly at 2 weeks, reductions in BMI, fat mass and BP were observed at 8 weeks, and waist-to-hip ratios and HOMA-IR were decreased at 12 weeks. In comparison, in the EX alone group, significant reductions of fat mass and HOMA-IR were observed at 4 weeks. Plasma NE and HOMA-IR were reduced at 8 weeks while decreases in BP were detected at 12 weeks. In the D+EX group, significant reductions in plasma NE were observed at 2 weeks followed by significant decreases in BMI, fat mass, waist-to-hip ratio, BP levels and HOMA-IR at 4 weeks. The magnitudes of reductions of all parameters were greatest in the D+EX group. These results demonstrate that D+EX exerts a stronger ameliorative effect on weight loss, weight loss-induced BP reduction, normalization of BP, sympathetic activation and insulin resistance compared with D or EX alone. D and EX might, perhaps, exert different mechanisms on weight loss and weight loss-induced BP reduction; however, a combination of caloric restriction and exercise is preferred to control BP levels in obese hypertensive patients.
The present study compared the effectiveness of a mild calorie-restricted diet (D) alone, exercise (EX) alone and a combination of D+EX on weight loss-induced blood pressure (BP) reduction over 24 weeks. We focussed especially on the relationship between sympathetic nervous activity, as indicated from measures of plasma norepinephrine (NE), and insulin resistance (homeostasis model of insulin resistance, HOMA-IR). The three groups each comprised 30 obese, hypertensive men. Body mass index (BMI), fat mass, waist-to-hip ratio, BP, plasma NE and HOMA-IR were measured every 2 weeks during the first 4 weeks and subsequently every 4 weeks for the next 20 weeks. All basal parameters were similar among the three groups. At 24 weeks, the combination group with D+EX comprised a significantly higher prevalence of normotensive subjects than the D alone or EX alone group (P<0.05). In the D alone group, plasma NE was decreased significantly at 2 weeks, reductions in BMI, fat mass and BP were observed at 8 weeks, and waist-to-hip ratios and HOMA-IR were decreased at 12 weeks. In comparison, in the EX alone group, significant reductions of fat mass and HOMA-IR were observed at 4 weeks. Plasma NE and HOMA-IR were reduced at 8 weeks while decreases in BP were detected at 12 weeks. In the D+EX group, significant reductions in plasma NE were observed at 2 weeks followed by significant decreases in BMI, fat mass, waist-to-hip ratio, BP levels and HOMA-IR at 4 weeks. The magnitudes of reductions of all parameters were greatest in the D+EX group. These results demonstrate that D+EX exerts a stronger ameliorative effect on weight loss, weight loss-induced BP reduction, normalization of BP, sympathetic activation and insulin resistance compared with D or EX alone. D and EX might, perhaps, exert different mechanisms on weight loss and weight loss-induced BP reduction; however, a combination of caloric restriction and exercise is preferred to control BP levels in obese hypertensive patients.
Author MASUO Kazuko
OGIHARA Toshio
W LAMBERT Gavin
RAKUGI Hiromi
Author_xml – sequence: 1
  givenname: Kazuko
  surname: Masuo
  fullname: Masuo, Kazuko
  email: kazuko.masuo@bakeridi.edu.au
  organization: Human Neurotransmitters Laboratory, Baker IDI Heart & Diabetes Institute, Nucleus Network Ltd, Baker IDI Heart & Diabetes Institute
– sequence: 2
  givenname: Hiromi
  surname: Rakugi
  fullname: Rakugi, Hiromi
  organization: Department of Geriatric Medicine and Nephrology, Osaka University Graduate School of Medicine
– sequence: 3
  givenname: Toshio
  surname: Ogihara
  fullname: Ogihara, Toshio
  organization: Department of Geriatric Medicine and Nephrology, Osaka University Graduate School of Medicine
– sequence: 4
  givenname: Gavin W
  surname: Lambert
  fullname: Lambert, Gavin W
  organization: Human Neurotransmitters Laboratory, Baker IDI Heart & Diabetes Institute, Faculty of Medicine, Nursing and Health Sciences, Monash University
BackLink https://cir.nii.ac.jp/crid/1570009750864846464$$DView record in CiNii
https://www.ncbi.nlm.nih.gov/pubmed/21814218$$D View this record in MEDLINE/PubMed
BookMark eNp1kU1rHSEUhqUkNDdpV90XF4Uu2rn1axxdhvQrEMimXYujZ3INM3qrDmn_fbzctItCEI4gz_sizzlHJzFFQOgNJVtKuPq0y1tGKN1SLl6gTZuqE4yKE7QhmspOSy7P0Hkp94Qw1Wv6Ep0xqmhj1AaVz2GaIEOseAG3szGUpeAQ8QOEu13FcyqlC9GvDjwe55Q83mcoZc2AM7TnGlLEI9QHgIgtdnZOOUDXmJqDqy3lA1Rso8fwG7ILBV6h08nOBV4_3Rfo59cvP66-dze3366vLm86JxStnR4EFR44I8xPnnMmxKCnXloYrZ48eMo5EBBstIKwkTvSD1yN2nHoh36c-AV6f-zd5_RrbR8ySygO5tlGSGsxmgopOZdDI98-keu4gDf7HBab_5i_nhrw4Qi43IRkmP4hlJjDFswum8MWTPPfaPof7UK1B1M12zA_k_l4zJTWHO8gm_u05tj8PIO_O-IxhNZ-mLQfCCF66ImSQgnZDn8E9O6kSw
CitedBy_id crossref_primary_10_1038_hr_2013_152
crossref_primary_10_1002_14651858_CD008274_pub4
crossref_primary_10_1016_j_smrv_2016_12_001
crossref_primary_10_1002_14651858_CD008274_pub3
crossref_primary_10_1159_000531798
crossref_primary_10_3390_foods13071079
crossref_primary_10_1152_ajpheart_00096_2015
crossref_primary_10_1038_hr_2016_142
crossref_primary_10_1016_j_ypmed_2018_07_007
crossref_primary_10_1152_japplphysiol_00362_2016
crossref_primary_10_1177_2047487319871233
crossref_primary_10_1111_obr_13269
crossref_primary_10_1093_pubmed_fdw077
crossref_primary_10_1016_j_metabol_2012_09_005
crossref_primary_10_3390_molecules26113168
crossref_primary_10_1080_10408398_2022_2064424
crossref_primary_10_1093_ajh_hpu050
crossref_primary_10_1292_jvms_13_0475
crossref_primary_10_1097_GME_0b013e3182831ee4
crossref_primary_10_7570_jomes_2019_28_4_278
crossref_primary_10_1007_s11906_014_0426_z
crossref_primary_10_1111_jch_12853
Cites_doi 10.1016/S0828-282X(10)70379-2
10.1111/j.1467-789X.2007.00393.x
10.1097/HJH.0b013e3283418875
10.1007/s11906-010-0168-5
10.1186/1471-2458-10-766
10.7326/0003-4819-142-8-200504190-00009
10.3945/ajcn.2008.26299
10.1097/00004872-200103001-00001
10.1093/ajh/7.5.402
10.1161/01.HYP.25.4.560
10.1161/01.HYP.0000037217.96002.8E
10.1590/S0100-879X2006000100006
10.1097/00005344-200000004-00001
10.1001/jama.2010.1505
10.2337/db08-1595
10.1016/S0895-7061(00)01279-6
10.1056/NEJMoa066603
10.1161/01.CIR.0000161959.04675.5A
10.7326/0003-4819-136-7-200204020-00006
10.1161/01.HYP.5.5.767
10.1161/01.HYP.4.5.686
10.1161/01.HYP.35.5.1135
10.5694/j.1326-5377.2009.tb02753.x
10.1001/jama.282.16.1519
10.1097/00004872-199816121-00019
10.1007/s11906-010-0135-1
10.1111/j.1600-0838.2006.00631.x
10.1161/HYPERTENSIONAHA.109.149153
10.1210/jc.2005-0961
10.1186/1471-2261-8-12
10.1152/ajpheart.01090.2002
10.1001/archinte.1984.00350200073012
10.2337/diacare.26.8.2426
10.1001/archinternmed.2009.470
10.1093/ajh/2.3.140S
10.1161/01.HYP.18.5.575
10.1053/j.jrn.2007.10.024
10.2174/157340210791171038
10.1291/hypres.24.371
10.1006/pmed.1999.0602
10.4061/2010/832821
10.1016/j.amjhyper.2004.09.011
10.1161/CIRCULATIONAHA.104.519652
10.1291/hypres.30.503
10.1046/j.1365-2796.2000.00568.x
10.1097/HJH.0b013e328302f10d
10.1161/hc1102.105261
10.1161/HYPERTENSIONAHA.109.146795
10.2337/db09-0934
10.1001/jama.289.1.76
10.1038/hr.2008.2
10.1161/HYPERTENSIONAHA.107.094649
10.1152/ajpendo.00469.2010
ContentType Journal Article
Copyright The Japanese Society of Hypertension 2012
Copyright_xml – notice: The Japanese Society of Hypertension 2012
DBID RYH
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1038/hr.2011.134
DatabaseName CiNii Complete
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Public Health
EISSN 1348-4214
EndPage 47
ExternalDocumentID 21814218
10_1038_hr_2011_134
10030642760
Genre Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
-Q-
0R~
29I
39C
4.4
406
53G
5GY
70F
7X7
AANZL
AASML
ABAKF
ABAWZ
ABBRH
ABDBE
ABFSG
ABJNI
ABLJU
ABZZP
ACAOD
ACGFO
ACGFS
ACKTT
ACMFV
ACMJI
ACRQY
ACSTC
ACZOJ
ADBBV
AEFQL
AEJRE
AEMSY
AENEX
AESKC
AEVLU
AEXYK
AEZWR
AFBBN
AFDZB
AFHIU
AFSHS
AGAYW
AGHAI
AGQEE
AHMBA
AHSBF
AHWEU
AIGIU
AILAN
AIXLP
AJRNO
ALFFA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMYLF
ATHPR
AXYYD
AYFIA
BKKNO
CS3
DNIVK
DPUIP
DU5
E3Z
EBLON
EBS
EE.
EIOEI
EJD
EMB
EMOBN
F5P
FDQFY
FERAY
FIZPM
FSGXE
FYUFA
GX1
HZ~
IWAJR
JSH
JSO
JZLTJ
NQJWS
O9-
OK1
P2P
RNT
RNTTT
ROL
RYH
SNX
SNYQT
SOHCF
SOJ
SRMVM
SV3
SWTZT
TAOOD
TBHMF
TDRGL
TSG
XSB
.55
2WC
88E
8FI
8FJ
AACDK
AATNV
ABRTQ
ABUWG
AFKRA
BAWUL
BENPR
BPHCQ
BVXVI
CCPQU
DIK
FIGPU
HMCUK
JSF
KQ8
LGEZI
LOTEE
M1P
NADUK
NXXTH
PHGZM
PHGZT
PJZUB
PPXIY
PQQKQ
PROAC
PSQYO
RJT
RZJ
TKC
TR2
UKHRP
W2D
X7M
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c481t-97414de3202dfd3324479f56aeba9fded133e0e42ba402b3c05738b9c3e575bf3
ISSN 0916-9636
1348-4214
IngestDate Fri Sep 05 13:59:03 EDT 2025
Mon Jul 21 06:05:06 EDT 2025
Thu Apr 24 23:09:21 EDT 2025
Tue Jul 01 04:12:20 EDT 2025
Mon Jul 21 06:08:40 EDT 2025
Thu Jun 26 23:41:52 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords insulin resistance
obesity
a calorie-restricted diet
an aerobic exercise
sympathetic nervous activity
Language English
License http://www.springer.com/tdm
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c481t-97414de3202dfd3324479f56aeba9fded133e0e42ba402b3c05738b9c3e575bf3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
ORCID 0000-0001-6508-4338
OpenAccessLink https://www.nature.com/articles/hr2011134.pdf
PMID 21814218
PQID 914663367
PQPubID 23479
PageCount 7
ParticipantIDs proquest_miscellaneous_914663367
pubmed_primary_21814218
crossref_primary_10_1038_hr_2011_134
crossref_citationtrail_10_1038_hr_2011_134
springer_journals_10_1038_hr_2011_134
nii_cinii_1570009750864846464
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2012-01-01
PublicationDateYYYYMMDD 2012-01-01
PublicationDate_xml – month: 01
  year: 2012
  text: 2012-01-01
  day: 01
PublicationDecade 2010
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle Hypertension research
PublicationTitleAbbrev Hypertens Res
PublicationTitleAlternate Hypertens Res
PublicationYear 2012
Publisher Nature Publishing Group UK
Publisher_xml – name: Nature Publishing Group UK
References JB Dixon (BFhr2011134_CR35) 2008; 299
MH Maxwell (BFhr2011134_CR44) 1994; 7
NE Straznicky (BFhr2011134_CR37) 2011; 29
NE Straznicky (BFhr2011134_CR56) 2009; 58
K Masuo (BFhr2011134_CR5) 2010; 2010
JSH 2009 (BFhr2011134_CR12) 2009; 32
BH Goodpaster (BFhr2011134_CR14) 2010; 304
WI Sivitz (BFhr2011134_CR48) 1999; 277
K Masuo (BFhr2011134_CR20) 2001; 14
TD Adams (BFhr2011134_CR34) 2007; 357
IT Meredith (BFhr2011134_CR49) 1991; 18
IM Claesson (BFhr2011134_CR21) 2010; 10
BFhr2011134_CR11
AH Mokdad (BFhr2011134_CR26) 1999; 282
LS Pescatello (BFhr2011134_CR55) 2008; 8
L Landsberg (BFhr2011134_CR3) 2001; 15
K Masuo (BFhr2011134_CR50) 1983; 5
K Masuo (BFhr2011134_CR40) 2005; 18
AH Mokdad (BFhr2011134_CR28) 2003; 289
NE Strazanicky (BFhr2011134_CR54) 2011; 29
K Masuo (BFhr2011134_CR4) 2005; 111
M Esler (BFhr2011134_CR6) 2000; 35
PJ Smith (BFhr2011134_CR18) 2010; 55
ER Miller III (BFhr2011134_CR15) 2002; 40
JR Sowers (BFhr2011134_CR43) 1982; 4
NE Straznicky (BFhr2011134_CR52) 2010; 50
M Esler (BFhr2011134_CR38) 1989; 2
SA Anderssen (BFhr2011134_CR32) 2007; 17
G Berglund (BFhr2011134_CR10) 2000; 247
MM Ribeiro (BFhr2011134_CR57) 2005; 111
G Grassi (BFhr2011134_CR1) 1995; 25
AS Poobalan (BFhr2011134_CR33) 2007; 8
JA Blumenthal (BFhr2011134_CR17) 2010; 55
TJ Orchard (BFhr2011134_CR31) 2005; 142
AL Himderliter (BFhr2011134_CR19) 2011; 13
IC Trombetta (BFhr2011134_CR58) 2003; 11
SP Whelton (BFhr2011134_CR16) 2002; 136
JA Blumenthal (BFhr2011134_CR53) 2010; 170
E Lambert (BFhr2011134_CR36) 2007; 50
L Gohler (BFhr2011134_CR46) 2000; 30
G Grassi (BFhr2011134_CR2) 1998; 16
GW Lambert (BFhr2011134_CR24) 2011; 6
NE Straznicky (BFhr2011134_CR47) 2005; 90
DG Hackam (BFhr2011134_CR13) 2010; 26
AC Tonacio (BFhr2011134_CR59) 2006; 39
GA Adesseun (BFhr2011134_CR22) 2010; 12
K Masuo (BFhr2011134_CR42) 2001; 24
K Masuo (BFhr2011134_CR7) 2007; 30
N Straznicky (BFhr2011134_CR41) 2009; 89
K Masuo (BFhr2011134_CR23) 2000; 35
DS Lee (BFhr2011134_CR27) 2009; 191
H Yokoyama (BFhr2011134_CR25) 2003; 26
C Zoccali (BFhr2011134_CR9) 2002; 105
MH Maxwell (BFhr2011134_CR51) 1984; 144
K Masuo (BFhr2011134_CR45) 2000; 36
G Mancia (BFhr2011134_CR29) 2008; 26
AJ Cameron (BFhr2011134_CR30) 2009; 191
AR Gosmanov (BFhr2011134_CR39) 2010; 299
A Ksiazek (BFhr2011134_CR8) 2008; 18
References_xml – ident: BFhr2011134_CR11
– volume: 26
  start-page: 249
  year: 2010
  ident: BFhr2011134_CR13
  publication-title: Can J Cardiol
  doi: 10.1016/S0828-282X(10)70379-2
– volume: 8
  start-page: 503
  year: 2007
  ident: BFhr2011134_CR33
  publication-title: Obes Rev
  doi: 10.1111/j.1467-789X.2007.00393.x
– volume: 29
  start-page: 553
  year: 2011
  ident: BFhr2011134_CR54
  publication-title: J Hypertens
  doi: 10.1097/HJH.0b013e3283418875
– volume: 13
  start-page: 67
  year: 2011
  ident: BFhr2011134_CR19
  publication-title: Curr Hypertens Rep
  doi: 10.1007/s11906-010-0168-5
– volume: 10
  start-page: 766
  year: 2010
  ident: BFhr2011134_CR21
  publication-title: BMC Public Health
  doi: 10.1186/1471-2458-10-766
– volume: 142
  start-page: 611
  year: 2005
  ident: BFhr2011134_CR31
  publication-title: Am Intern Med
  doi: 10.7326/0003-4819-142-8-200504190-00009
– volume: 89
  start-page: 27
  year: 2009
  ident: BFhr2011134_CR41
  publication-title: Am J Clin Nutr
  doi: 10.3945/ajcn.2008.26299
– volume: 15
  start-page: 523
  year: 2001
  ident: BFhr2011134_CR3
  publication-title: J Hypertens
  doi: 10.1097/00004872-200103001-00001
– volume: 7
  start-page: 402
  year: 1994
  ident: BFhr2011134_CR44
  publication-title: Am J Hypertens
  doi: 10.1093/ajh/7.5.402
– volume: 25
  start-page: 560
  issue: Pt 1
  year: 1995
  ident: BFhr2011134_CR1
  publication-title: Hypertension
  doi: 10.1161/01.HYP.25.4.560
– volume: 40
  start-page: 612
  year: 2002
  ident: BFhr2011134_CR15
  publication-title: Hypertension
  doi: 10.1161/01.HYP.0000037217.96002.8E
– volume: 39
  start-page: 53
  year: 2006
  ident: BFhr2011134_CR59
  publication-title: Braz J Med Biol Res
  doi: 10.1590/S0100-879X2006000100006
– volume: 35
  start-page: S1
  issue: Suppl 4
  year: 2000
  ident: BFhr2011134_CR6
  publication-title: J Cardiovasc Pharmacol
  doi: 10.1097/00005344-200000004-00001
– volume: 304
  start-page: 1795
  year: 2010
  ident: BFhr2011134_CR14
  publication-title: JAMA
  doi: 10.1001/jama.2010.1505
– volume: 29
  start-page: 553
  year: 2011
  ident: BFhr2011134_CR37
  publication-title: J Hypertens
  doi: 10.1097/HJH.0b013e3283418875
– volume: 58
  start-page: 1126
  year: 2009
  ident: BFhr2011134_CR56
  publication-title: Diabetes
  doi: 10.2337/db08-1595
– volume: 14
  start-page: 530
  issue: Pt 1
  year: 2001
  ident: BFhr2011134_CR20
  publication-title: Am J Hypertens
  doi: 10.1016/S0895-7061(00)01279-6
– volume: 357
  start-page: 753
  year: 2007
  ident: BFhr2011134_CR34
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa066603
– volume: 111
  start-page: 1915
  year: 2005
  ident: BFhr2011134_CR57
  publication-title: Circulation
  doi: 10.1161/01.CIR.0000161959.04675.5A
– volume: 136
  start-page: 493
  year: 2002
  ident: BFhr2011134_CR16
  publication-title: An Intern Med
  doi: 10.7326/0003-4819-136-7-200204020-00006
– volume: 5
  start-page: 767
  year: 1983
  ident: BFhr2011134_CR50
  publication-title: Hypertension
  doi: 10.1161/01.HYP.5.5.767
– volume: 4
  start-page: 686
  year: 1982
  ident: BFhr2011134_CR43
  publication-title: Hypertension
  doi: 10.1161/01.HYP.4.5.686
– volume: 299
  start-page: 316
  year: 2008
  ident: BFhr2011134_CR35
  publication-title: JAMA
– volume: 35
  start-page: 1135
  year: 2000
  ident: BFhr2011134_CR23
  publication-title: Hypertension
  doi: 10.1161/01.HYP.35.5.1135
– volume: 191
  start-page: 202
  year: 2009
  ident: BFhr2011134_CR30
  publication-title: Med J Aust
  doi: 10.5694/j.1326-5377.2009.tb02753.x
– volume: 282
  start-page: 1519
  year: 1999
  ident: BFhr2011134_CR26
  publication-title: JAMA
  doi: 10.1001/jama.282.16.1519
– volume: 16
  start-page: 1979
  issue: Pt 2
  year: 1998
  ident: BFhr2011134_CR2
  publication-title: J Hypertens
  doi: 10.1097/00004872-199816121-00019
– volume: 12
  start-page: 378
  year: 2010
  ident: BFhr2011134_CR22
  publication-title: Curr Hypertens Rep
  doi: 10.1007/s11906-010-0135-1
– volume: 17
  start-page: 687
  year: 2007
  ident: BFhr2011134_CR32
  publication-title: Scand J Med Sci Sports
  doi: 10.1111/j.1600-0838.2006.00631.x
– volume: 55
  start-page: 1199
  year: 2010
  ident: BFhr2011134_CR17
  publication-title: Hypertension
  doi: 10.1161/HYPERTENSIONAHA.109.149153
– volume: 90
  start-page: 5998
  year: 2005
  ident: BFhr2011134_CR47
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2005-0961
– volume: 8
  start-page: 12
  year: 2008
  ident: BFhr2011134_CR55
  publication-title: BMC Cardiovascular Disorders
  doi: 10.1186/1471-2261-8-12
– volume: 11
  start-page: H974
  year: 2003
  ident: BFhr2011134_CR58
  publication-title: Am J Physiol Heart Circ Physiol
  doi: 10.1152/ajpheart.01090.2002
– volume: 144
  start-page: 1581
  year: 1984
  ident: BFhr2011134_CR51
  publication-title: Arch Intern Med
  doi: 10.1001/archinte.1984.00350200073012
– volume: 26
  start-page: 2426
  year: 2003
  ident: BFhr2011134_CR25
  publication-title: Diabetes Care
  doi: 10.2337/diacare.26.8.2426
– volume: 170
  start-page: 126
  year: 2010
  ident: BFhr2011134_CR53
  publication-title: Arch Intern Med
  doi: 10.1001/archinternmed.2009.470
– volume: 277
  start-page: E668
  issue: Pt 1
  year: 1999
  ident: BFhr2011134_CR48
  publication-title: Am J Physiol
– volume: 2
  start-page: S140
  year: 1989
  ident: BFhr2011134_CR38
  publication-title: Am J Hypertens
  doi: 10.1093/ajh/2.3.140S
– volume: 18
  start-page: 575
  year: 1991
  ident: BFhr2011134_CR49
  publication-title: Hypertension
  doi: 10.1161/01.HYP.18.5.575
– volume: 18
  start-page: 118
  year: 2008
  ident: BFhr2011134_CR8
  publication-title: J Ren Nutr
  doi: 10.1053/j.jrn.2007.10.024
– volume: 6
  start-page: 130
  year: 2011
  ident: BFhr2011134_CR24
  publication-title: Curr Hypertens Rev
  doi: 10.2174/157340210791171038
– volume: 24
  start-page: 371
  year: 2001
  ident: BFhr2011134_CR42
  publication-title: Hypertens Res
  doi: 10.1291/hypres.24.371
– volume: 30
  start-page: 95
  year: 2000
  ident: BFhr2011134_CR46
  publication-title: Prev Med
  doi: 10.1006/pmed.1999.0602
– volume: 2010
  start-page: 832821
  year: 2010
  ident: BFhr2011134_CR5
  publication-title: Int J Hypertens
  doi: 10.4061/2010/832821
– volume: 191
  start-page: E55
  year: 2009
  ident: BFhr2011134_CR27
  publication-title: CMAJ
– volume: 36
  start-page: 17
  issue: Suppl 2
  year: 2000
  ident: BFhr2011134_CR45
  publication-title: Hypertension
– volume: 18
  start-page: 235
  issue: 2 Pt 1
  year: 2005
  ident: BFhr2011134_CR40
  publication-title: Am J Hypertens
  doi: 10.1016/j.amjhyper.2004.09.011
– volume: 111
  start-page: 3429
  year: 2005
  ident: BFhr2011134_CR4
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.104.519652
– volume: 30
  start-page: 503
  year: 2007
  ident: BFhr2011134_CR7
  publication-title: Hypertens Res
  doi: 10.1291/hypres.30.503
– volume: 247
  start-page: 19
  year: 2000
  ident: BFhr2011134_CR10
  publication-title: J Intern Med
  doi: 10.1046/j.1365-2796.2000.00568.x
– volume: 26
  start-page: 1602
  year: 2008
  ident: BFhr2011134_CR29
  publication-title: J Hypertens
  doi: 10.1097/HJH.0b013e328302f10d
– volume: 105
  start-page: 1354
  year: 2002
  ident: BFhr2011134_CR9
  publication-title: Circulation
  doi: 10.1161/hc1102.105261
– volume: 55
  start-page: 1331
  year: 2010
  ident: BFhr2011134_CR18
  publication-title: Hypertension
  doi: 10.1161/HYPERTENSIONAHA.109.146795
– volume: 50
  start-page: 71
  year: 2010
  ident: BFhr2011134_CR52
  publication-title: Diabetes
  doi: 10.2337/db09-0934
– volume: 289
  start-page: 76
  year: 2003
  ident: BFhr2011134_CR28
  publication-title: JAMA
  doi: 10.1001/jama.289.1.76
– volume: 32
  start-page: 11
  year: 2009
  ident: BFhr2011134_CR12
  publication-title: Hypertens Res
  doi: 10.1038/hr.2008.2
– volume: 50
  start-page: 862
  year: 2007
  ident: BFhr2011134_CR36
  publication-title: Hypertension
  doi: 10.1161/HYPERTENSIONAHA.107.094649
– volume: 299
  start-page: E953
  year: 2010
  ident: BFhr2011134_CR39
  publication-title: Am J Physiol Endocrinol Metab
  doi: 10.1152/ajpendo.00469.2010
SSID ssj0028591
Score 2.1198494
Snippet The present study compared the effectiveness of a mild calorie-restricted diet (D) alone, exercise (EX) alone and a combination of D+EX on weight loss-induced...
SourceID proquest
pubmed
crossref
springer
nii
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 41
SubjectTerms a calorie-restricted diet
Adult
an aerobic exercise
Blood Pressure - physiology
Body Mass Index
Diet, Reducing
Exercise - physiology
Geriatrics/Gerontology
Health Promotion and Disease Prevention
Humans
Hypertension - complications
Hypertension - physiopathology
insulin resistance
Insulin Resistance - physiology
Internal Medicine
Male
Medicine
Medicine & Public Health
Middle Aged
Norepinephrine - blood
obesity
Obesity - complications
Obesity - physiopathology
Obstetrics/Perinatology/Midwifery
original-article
Public Health
sympathetic nervous activity
Waist-Hip Ratio
Weight Loss - physiology
Title Different mechanisms in weight loss-induced blood pressure reduction between a calorie-restricted diet and exercise
URI https://cir.nii.ac.jp/crid/1570009750864846464
https://link.springer.com/article/10.1038/hr.2011.134
https://www.ncbi.nlm.nih.gov/pubmed/21814218
https://www.proquest.com/docview/914663367
Volume 35
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb5tAEF41iVT1UvUd0qbaQ3qpRQrsYvAxaeNaleNebNU3BMsSo8RQgUml_PrO7C7Yli31IUvIQnjBfB_DvIeQM5kBK_wgtgMmfJu7Utghyxyc9SLhAeGBVO2arif90Yx_m_vzdQRfVZesknPxsLeu5H9QhX2AK1bJ_gOy3aKwA74DvrAFhGH7Vxh_MdNNVr2lxArevF6q9NZfyt_Zu4MXoA02d4MxfpWh3lNprxgzqLBlq8K-zdSKewBXCZazjeM6QDyiLprmUqegt6OZNpXZEdiwlcqAL7EoZsMvplzcdVPqfI2H5rZcx5Numxs9KTuvymXeOXlvcmwdrehT1ou8-8E4xpEl6lXxNb6HP_dj01GhMj5aR4WWrQx9l56uGT2Xe_YZgaz7l2wRT0tX3SJrR-jrFu-LSjdkdY1zdKu19uR7NJyNx9H0aj49IEdeEGBM_-hieHk56exzbOWn7HNzTaacE5b_tLH4lgJzUOT5PttkJ66u1JXpM_LU2Bn0QpPmOXkkixfk8bXJpHhJ6o47dM0dmhdUc4ducocq7tCWO7TjDjXcoTHd5Q5F7lDgDm2584rMhlfTzyPbDOCwBQ_dlQ22pstTyTzHS7OUge7Ng0Hm92OZxIMslanLmHQk95KYO17CBHbXDJOBYBKsgCRjr8lhURbymNAkEKnn-E7MBi6H-xyC6Beg_nuSg40aCIt8bO9qJEx3ehySchepLAkWRosqQggigMAiZ93BP3VTlv2HnQI8sBxuXRzk4AxAQQ77HJRu-FiEtsBFIFQxUhYXsmzqCK4RNHHWDyzyRgPanQdVYiBHaJEPLcKREQn1vos4-fNJ3pIn6-flHTlcVY08BVV3lbw3FP0NZ7iq_A
linkProvider Library Specific Holdings
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Different+mechanisms+in+weight+loss-induced+blood+pressure+reduction+between+a+calorie-restricted+diet+and+exercise&rft.jtitle=Hypertension+research&rft.au=Masuo%2C+Kazuko&rft.au=Rakugi%2C+Hiromi&rft.au=Ogihara%2C+Toshio&rft.au=Lambert%2C+Gavin+W&rft.date=2012-01-01&rft.issn=1348-4214&rft.eissn=1348-4214&rft.volume=35&rft.issue=1&rft.spage=41&rft_id=info:doi/10.1038%2Fhr.2011.134&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0916-9636&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0916-9636&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0916-9636&client=summon